SWEDISH ORPHAN BIOVITRUM AS
976313682ActiveGlobal biopharma company developing innovative treatments for rare diseases.
Biopharmaceutical Companysobi.no
Oversigt
- 7
- Medarbejdere
- 35.7mio NOK
- Omsætning
- 1996
- Grundlagt
Nøglebeslutningstagere
Gerard Tobin
Head of Investor Relations
@sobi.com+41792XXXXXX
Iris Loew-Friedrich
Board member
@sobi.com
Zlatko Rihter
Board member
@sobi.com
Daniel Rankin
Head of Strategy & Corporate Development
@sobi.com
+22 flere kontakter i Funnelfeedr
Beskrivelse
Sobi, officially Swedish Orphan Biovitrum AB, is a global biopharmaceutical company dedicated to rare diseases. Its core mission is to develop and ensure access to innovative treatments that significantly transform the lives of individuals living with these conditions. The organization concentrates...